Facilitated By

San Antonio Medical Foundation

2562 Results Page 1 of 257

A Phase 3, Open Label, Randomized Study Of LOXO-305 Versus Investigator’s Choice Of Idelalisib Plus Rituximab Or Bendamustine Plus Rituximab In Btk Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Funded by
HJF

The primary objective of the study is to evaluate progression-free survival of LOXO-305 as monotherapy (Arm A) versus either idelalisib plus rituximab or bendamustine plus rituximab (Arm B).

Collaborative Project
Active Project
Cancer
Clinical Care

Effective Surveillance Of Chagas Disease For Us Military Readiness Along South West Us Mexico Border Ports Of Entry

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Funded by
Texas State University

The goals of this project are to conduct vector and human surveillance of Chagas disease, and to propose policies for improved surveillance of this emerging infectious threat to our Service member population who reside and conduct training in potentially high risk areas.

Collaborative Project
Active Project
Infectious Disease
Clinical Care

An Open-Label Study To Assess The Anti-Tumor Activity And Safety Of REGN1979, An Anti-CD20 X Anti-CD3 Bispecific Antibody, In Patients With Relapsed Or Refractory Follicular Lymphoma

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Funded by
Geneva

This joint research project will benefit the Collaborating Party by accomplishing its mission to promote and support the advancement of military medicine and specifically military medical research. The project will benefit the Federal Laboratory by providing valuable research experience for the staff involved. In addition, patients at BAMC with relapsed or refractory follicular lymphoma may benefit through potential use of REGN1979

Collaborative Project
Active Project
Cancer
Clinical Care

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 12-Week Study To Assess The Efficacy And Safety Of Etrasimod In Subjects With Moderately To Severely Active Ulcerative C

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Funded by
Geneva

The primary objective of this study is to assess the efficacy of Etrasimod when administered for twelve (12) weeks on clinical remission in subjects with moderately to severely Active Ulcerative Colitis (UC).

Collaborative Project
Active Project
Infectious Disease
Clinical Care

Entyvio (Vedolizumab) Long-Term Safety Study: An International Observational Prospective Cohort Study Comparing Vedolizumab To Other Biologic Agents In Patients With Ulcerative Colitis Or Crohn's Disease

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Funded by
Geneva

The Overall Study Sponsor has developed a study to assess the safety of vedolizumab versus other biologic agents in the real world setting. The participating physicians will be representative of the gastroenterologists who prescribe vedolizumab, or other biologic agents, per the local prescribing information in the participating countries.

Collaborative Project
Active Project
Infectious Disease
Clinical Care

The aim of the present study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information

The aim of the present study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.

Collaborative Project
Active Project
Infectious Disease
Clinical Care

Adaptive Platform Treatment Trial For Outpatients With Covid-19

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Funded by
Geneva

This RDTE project will benefit the Collaborating Party by accomplishing its mission to promote and support the advancement of military medicine and specifically military medical research. The RDTE project will benefit the BAMC by providing valuable research experience for the staff involved. In addition, patients at BAMC with COVID-19 may benefit from the medical treatment.

Collaborative Project
Active Project
Infectious Disease
Clinical Care

Phase III Randomized, Double-Blind, Placebo-Controlled Multicenter Study In Adults To Determine The Safety, Efficacy, And Immunogenicity Of AZD1222, A Non-Replicating ChADOxi Vector Vaccine, For The Prevention Of COVID-19

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Funded by
Geneva

The aim of the present study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19.

Collaborative Project
Active Project
Infectious Disease
Clinical Care

Development of Persistent Musculoskeletal Pain in the Military: The Prediction of Outcomes, Utilization, and Readiness after Surgery (POURS) Cohort for Knee and Shoulder

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Funded by
Geneva

This joint research project will benefit the Collaborating Party by accomplishing its mission to promote and support the advancement of military medicine and specifically military medical research. The project will benefit the Federal Laboratory by providing valuable research experience for the staff involved.

Collaborative Project
Active Project
Musculoskeletal
Clinical Care

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Study Of Acalabrutinib In Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, And Prednisone (R-CHOP) In Subjects >65 Years With Previously Untreated Non-Germinal Center Diffuse Large B-Cell Lymphoma

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Principal Investigator(s)
Email for information
Funded by
HJF

The primary objective of the study is to evaluate the effect of adding acalabrutinib to R-CHOP for progression-free survival in previously untreated non-germinal center diffuse large B-cell lymphoma.

Collaborative Project
Active Project
Cancer
Clinical Care